Global Subcutaneous Drug Delivery Devices Market
Global Subcutaneous Drug Delivery Devices Market

Subcutaneous Drug Delivery Devices Comprehensive Study by Type (Prefilled syringes, Pen injectors, Auto-injectors, Wearable injectors, Needle-free Injectors), Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), Syringe (Prefilled Injectable, Filled Injectable) Players and Region - Global Market Outlook to 2025

Subcutaneous Drug Delivery Devices Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Nov 2020 Edition 208 Pages 215 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Subcutaneous Drug Delivery Devices Market Scope
Subcutaneous Drug Delivery Devices refer to tools that are made for the delivery of a drug or therapeutic agent via the specific route of administration. Such devices are used as a part of one or more medical treatments. These devices help in increasing the efficiency of drug delivery system by controlling dosage, time, and place of release of the drugs in the body. The rising demand for subcutaneous drug delivery is attributed to the rapid development of biologics. Moreover, the subcutaneous route of administration is generally preferred, as it enables self-medication, improves the quality of life, and thus reduces healthcare costs. The market for subcutaneous drug delivery devices is increasing due to the rising accessibility and affordability of the drug delivery devices, whereas strict regulatory requirements for approval of subcutaneous drug delivery devices may hinder the market growth.

The Subcutaneous Drug Delivery Devices market study is segmented by Type (Prefilled syringes, Pen injectors, Auto-injectors, Wearable injectors and Needle-free Injectors) and major geographies with country level break-up.

The global Subcutaneous Drug Delivery Devices market including many local as well as regional players. Leading global players are focusing on strategic partnerships to improve their products and services. In addition, companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Subcutaneous Drug Delivery Devices market throughout the predicted period.

Gerresheimer AG (Germany), Medtronic Plc (United States), Ypsomed AG (Switzerland), Elcam Medical Group (Israel), Novo Nordisk (Denmark), Insulet Corporation (United States), Becton, Dickinson and Company (United States), West Pharmaceutical Services, Inc. (United States), Sanofi. (France) and PharmaJet (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Unilife Corporation (United States) and Inolife Sciences (Canada).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Subcutaneous Drug Delivery Devices market by Type, Application and Region.

On the basis of geography, the market of Subcutaneous Drug Delivery Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

in March 2018, Sanofi S.A. announced the U.S. FDA approval for its maximum unit injection pen - Toujeo Max SoloStar. The device is designed to accommodate a volume of 900 units/mL. The device will help in reducing injection numbers and thus lower medical spending.


Market Trend
  • Increasing product innovations and approvals

Market Drivers
  • Rising prevalence of chronic diseases
  • Increasing focus on self-administration, prevention of needlestick injuries and dosing errors

Opportunities
  • Improving economic conditions in the region
  • Rising geriatric population, technological advancements, and increasing demand for improved subcutaneousdrug delivery systems

Restraints
  • High cost of advanced delivery systems

Challenges
  • Strict regulatory requirements for approval of subcutaneous drug delivery devices
  • Problems related to the use of drug delivery devices such as dosage error


Key Target Audience
Subcutaneous Drug Delivery Devices Industry Investors, Subcutaneous Drug Delivery Devices Providers/Vendors, Research Professionals, Emerging Companies, Raw Material Suppliers/ Buyers, Research Institutes, Original Equipment Manufacturer, Component Supplier, Distributors, Government Body & Associations and End-user

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Prefilled syringes
  • Pen injectors
  • Auto-injectors
  • Wearable injectors
  • Needle-free Injectors
By Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies

By Syringe
  • Prefilled Injectable
  • Filled Injectable

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising prevalence of chronic diseases
      • 3.2.2. Increasing focus on self-administration, prevention of needlestick injuries and dosing errors
    • 3.3. Market Challenges
      • 3.3.1. Strict regulatory requirements for approval of subcutaneous drug delivery devices
      • 3.3.2. Problems related to the use of drug delivery devices such as dosage error
    • 3.4. Market Trends
      • 3.4.1. Increasing product innovations and approvals
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Subcutaneous Drug Delivery Devices, by Type, Distribution Channel, Syringe and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Subcutaneous Drug Delivery Devices (Value)
      • 5.2.1. Global Subcutaneous Drug Delivery Devices by: Type (Value)
        • 5.2.1.1. Prefilled syringes
        • 5.2.1.2. Pen injectors
        • 5.2.1.3. Auto-injectors
        • 5.2.1.4. Wearable injectors
        • 5.2.1.5. Needle-free Injectors
      • 5.2.2. Global Subcutaneous Drug Delivery Devices by: Distribution Channel (Value)
        • 5.2.2.1. Hospital pharmacies
        • 5.2.2.2. Retail pharmacies
        • 5.2.2.3. Online pharmacies
      • 5.2.3. Global Subcutaneous Drug Delivery Devices by: Syringe (Value)
        • 5.2.3.1. Prefilled Injectable
        • 5.2.3.2. Filled Injectable
      • 5.2.4. Global Subcutaneous Drug Delivery Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Subcutaneous Drug Delivery Devices (Volume)
      • 5.3.1. Global Subcutaneous Drug Delivery Devices by: Type (Volume)
        • 5.3.1.1. Prefilled syringes
        • 5.3.1.2. Pen injectors
        • 5.3.1.3. Auto-injectors
        • 5.3.1.4. Wearable injectors
        • 5.3.1.5. Needle-free Injectors
      • 5.3.2. Global Subcutaneous Drug Delivery Devices by: Distribution Channel (Volume)
        • 5.3.2.1. Hospital pharmacies
        • 5.3.2.2. Retail pharmacies
        • 5.3.2.3. Online pharmacies
      • 5.3.3. Global Subcutaneous Drug Delivery Devices by: Syringe (Volume)
        • 5.3.3.1. Prefilled Injectable
        • 5.3.3.2. Filled Injectable
      • 5.3.4. Global Subcutaneous Drug Delivery Devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Subcutaneous Drug Delivery Devices (Price)
      • 5.4.1. Global Subcutaneous Drug Delivery Devices by: Type (Price)
  • 6. Subcutaneous Drug Delivery Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Gerresheimer AG (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic Plc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ypsomed AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elcam Medical Group (Israel)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Novo Nordisk (Denmark)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Insulet Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Becton, Dickinson and Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. West Pharmaceutical Services, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sanofi. (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. PharmaJet (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Subcutaneous Drug Delivery Devices Sale, by Type, Distribution Channel, Syringe and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Subcutaneous Drug Delivery Devices (Value)
      • 7.2.1. Global Subcutaneous Drug Delivery Devices by: Type (Value)
        • 7.2.1.1. Prefilled syringes
        • 7.2.1.2. Pen injectors
        • 7.2.1.3. Auto-injectors
        • 7.2.1.4. Wearable injectors
        • 7.2.1.5. Needle-free Injectors
      • 7.2.2. Global Subcutaneous Drug Delivery Devices by: Distribution Channel (Value)
        • 7.2.2.1. Hospital pharmacies
        • 7.2.2.2. Retail pharmacies
        • 7.2.2.3. Online pharmacies
      • 7.2.3. Global Subcutaneous Drug Delivery Devices by: Syringe (Value)
        • 7.2.3.1. Prefilled Injectable
        • 7.2.3.2. Filled Injectable
      • 7.2.4. Global Subcutaneous Drug Delivery Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Subcutaneous Drug Delivery Devices (Volume)
      • 7.3.1. Global Subcutaneous Drug Delivery Devices by: Type (Volume)
        • 7.3.1.1. Prefilled syringes
        • 7.3.1.2. Pen injectors
        • 7.3.1.3. Auto-injectors
        • 7.3.1.4. Wearable injectors
        • 7.3.1.5. Needle-free Injectors
      • 7.3.2. Global Subcutaneous Drug Delivery Devices by: Distribution Channel (Volume)
        • 7.3.2.1. Hospital pharmacies
        • 7.3.2.2. Retail pharmacies
        • 7.3.2.3. Online pharmacies
      • 7.3.3. Global Subcutaneous Drug Delivery Devices by: Syringe (Volume)
        • 7.3.3.1. Prefilled Injectable
        • 7.3.3.2. Filled Injectable
      • 7.3.4. Global Subcutaneous Drug Delivery Devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Subcutaneous Drug Delivery Devices (Price)
      • 7.4.1. Global Subcutaneous Drug Delivery Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Subcutaneous Drug Delivery Devices: by Type(USD Million)
  • Table 2. Subcutaneous Drug Delivery Devices Prefilled syringes , by Region USD Million (2014-2019)
  • Table 3. Subcutaneous Drug Delivery Devices Pen injectors , by Region USD Million (2014-2019)
  • Table 4. Subcutaneous Drug Delivery Devices Auto-injectors , by Region USD Million (2014-2019)
  • Table 5. Subcutaneous Drug Delivery Devices Wearable injectors , by Region USD Million (2014-2019)
  • Table 6. Subcutaneous Drug Delivery Devices Needle-free Injectors , by Region USD Million (2014-2019)
  • Table 7. Subcutaneous Drug Delivery Devices: by Distribution Channel(USD Million)
  • Table 8. Subcutaneous Drug Delivery Devices Hospital pharmacies , by Region USD Million (2014-2019)
  • Table 9. Subcutaneous Drug Delivery Devices Retail pharmacies , by Region USD Million (2014-2019)
  • Table 10. Subcutaneous Drug Delivery Devices Online pharmacies , by Region USD Million (2014-2019)
  • Table 11. Subcutaneous Drug Delivery Devices: by Syringe(USD Million)
  • Table 12. Subcutaneous Drug Delivery Devices Prefilled Injectable , by Region USD Million (2014-2019)
  • Table 13. Subcutaneous Drug Delivery Devices Filled Injectable , by Region USD Million (2014-2019)
  • Table 14. South America Subcutaneous Drug Delivery Devices, by Country USD Million (2014-2019)
  • Table 15. South America Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 16. South America Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 17. South America Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 18. Brazil Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 19. Brazil Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 20. Brazil Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 21. Argentina Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 22. Argentina Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 23. Argentina Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 24. Rest of South America Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 25. Rest of South America Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 26. Rest of South America Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 27. Asia Pacific Subcutaneous Drug Delivery Devices, by Country USD Million (2014-2019)
  • Table 28. Asia Pacific Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 29. Asia Pacific Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 30. Asia Pacific Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 31. China Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 32. China Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 33. China Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 34. Japan Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 35. Japan Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 36. Japan Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 37. India Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 38. India Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 39. India Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 40. South Korea Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 41. South Korea Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 42. South Korea Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 43. Taiwan Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 44. Taiwan Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 45. Taiwan Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 46. Australia Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 47. Australia Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 48. Australia Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 49. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 50. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 51. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 52. Europe Subcutaneous Drug Delivery Devices, by Country USD Million (2014-2019)
  • Table 53. Europe Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 54. Europe Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 55. Europe Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 56. Germany Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 57. Germany Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 58. Germany Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 59. France Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 60. France Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 61. France Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 62. Italy Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 63. Italy Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 64. Italy Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 65. United Kingdom Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 66. United Kingdom Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 67. United Kingdom Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 68. Netherlands Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 69. Netherlands Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 70. Netherlands Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 71. Rest of Europe Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 72. Rest of Europe Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 73. Rest of Europe Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 74. MEA Subcutaneous Drug Delivery Devices, by Country USD Million (2014-2019)
  • Table 75. MEA Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 76. MEA Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 77. MEA Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 78. Middle East Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 79. Middle East Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 80. Middle East Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 81. Africa Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 82. Africa Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 83. Africa Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 84. North America Subcutaneous Drug Delivery Devices, by Country USD Million (2014-2019)
  • Table 85. North America Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 86. North America Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 87. North America Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 88. United States Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 89. United States Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 90. United States Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 91. Canada Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 92. Canada Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 93. Canada Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 94. Mexico Subcutaneous Drug Delivery Devices, by Type USD Million (2014-2019)
  • Table 95. Mexico Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2014-2019)
  • Table 96. Mexico Subcutaneous Drug Delivery Devices, by Syringe USD Million (2014-2019)
  • Table 97. Subcutaneous Drug Delivery Devices Sales: by Type(K Unit)
  • Table 98. Subcutaneous Drug Delivery Devices Sales Prefilled syringes , by Region K Unit (2014-2019)
  • Table 99. Subcutaneous Drug Delivery Devices Sales Pen injectors , by Region K Unit (2014-2019)
  • Table 100. Subcutaneous Drug Delivery Devices Sales Auto-injectors , by Region K Unit (2014-2019)
  • Table 101. Subcutaneous Drug Delivery Devices Sales Wearable injectors , by Region K Unit (2014-2019)
  • Table 102. Subcutaneous Drug Delivery Devices Sales Needle-free Injectors , by Region K Unit (2014-2019)
  • Table 103. Subcutaneous Drug Delivery Devices Sales: by Distribution Channel(K Unit)
  • Table 104. Subcutaneous Drug Delivery Devices Sales Hospital pharmacies , by Region K Unit (2014-2019)
  • Table 105. Subcutaneous Drug Delivery Devices Sales Retail pharmacies , by Region K Unit (2014-2019)
  • Table 106. Subcutaneous Drug Delivery Devices Sales Online pharmacies , by Region K Unit (2014-2019)
  • Table 107. Subcutaneous Drug Delivery Devices Sales: by Syringe(K Unit)
  • Table 108. Subcutaneous Drug Delivery Devices Sales Prefilled Injectable , by Region K Unit (2014-2019)
  • Table 109. Subcutaneous Drug Delivery Devices Sales Filled Injectable , by Region K Unit (2014-2019)
  • Table 110. South America Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2014-2019)
  • Table 111. South America Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 112. South America Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 113. South America Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 114. Brazil Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 115. Brazil Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 116. Brazil Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 117. Argentina Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 118. Argentina Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 119. Argentina Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 120. Rest of South America Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 121. Rest of South America Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 122. Rest of South America Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 123. Asia Pacific Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2014-2019)
  • Table 124. Asia Pacific Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 125. Asia Pacific Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 126. Asia Pacific Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 127. China Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 128. China Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 129. China Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 130. Japan Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 131. Japan Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 132. Japan Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 133. India Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 134. India Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 135. India Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 136. South Korea Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 137. South Korea Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 138. South Korea Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 139. Taiwan Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 140. Taiwan Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 141. Taiwan Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 142. Australia Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 143. Australia Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 144. Australia Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 145. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 146. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 147. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 148. Europe Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2014-2019)
  • Table 149. Europe Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 150. Europe Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 151. Europe Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 152. Germany Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 153. Germany Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 154. Germany Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 155. France Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 156. France Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 157. France Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 158. Italy Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 159. Italy Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 160. Italy Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 161. United Kingdom Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 162. United Kingdom Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 163. United Kingdom Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 164. Netherlands Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 165. Netherlands Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 166. Netherlands Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 167. Rest of Europe Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 168. Rest of Europe Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 169. Rest of Europe Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 170. MEA Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2014-2019)
  • Table 171. MEA Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 172. MEA Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 173. MEA Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 174. Middle East Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 175. Middle East Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 176. Middle East Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 177. Africa Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 178. Africa Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 179. Africa Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 180. North America Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2014-2019)
  • Table 181. North America Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 182. North America Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 183. North America Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 184. United States Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 185. United States Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 186. United States Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 187. Canada Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 188. Canada Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 189. Canada Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 190. Mexico Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2014-2019)
  • Table 191. Mexico Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2014-2019)
  • Table 192. Mexico Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2014-2019)
  • Table 193. Subcutaneous Drug Delivery Devices: by Type(USD/Units)
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Subcutaneous Drug Delivery Devices: by Type(USD Million)
  • Table 205. Subcutaneous Drug Delivery Devices Prefilled syringes , by Region USD Million (2020-2025)
  • Table 206. Subcutaneous Drug Delivery Devices Pen injectors , by Region USD Million (2020-2025)
  • Table 207. Subcutaneous Drug Delivery Devices Auto-injectors , by Region USD Million (2020-2025)
  • Table 208. Subcutaneous Drug Delivery Devices Wearable injectors , by Region USD Million (2020-2025)
  • Table 209. Subcutaneous Drug Delivery Devices Needle-free Injectors , by Region USD Million (2020-2025)
  • Table 210. Subcutaneous Drug Delivery Devices: by Distribution Channel(USD Million)
  • Table 211. Subcutaneous Drug Delivery Devices Hospital pharmacies , by Region USD Million (2020-2025)
  • Table 212. Subcutaneous Drug Delivery Devices Retail pharmacies , by Region USD Million (2020-2025)
  • Table 213. Subcutaneous Drug Delivery Devices Online pharmacies , by Region USD Million (2020-2025)
  • Table 214. Subcutaneous Drug Delivery Devices: by Syringe(USD Million)
  • Table 215. Subcutaneous Drug Delivery Devices Prefilled Injectable , by Region USD Million (2020-2025)
  • Table 216. Subcutaneous Drug Delivery Devices Filled Injectable , by Region USD Million (2020-2025)
  • Table 217. South America Subcutaneous Drug Delivery Devices, by Country USD Million (2020-2025)
  • Table 218. South America Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 219. South America Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 220. South America Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 221. Brazil Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 222. Brazil Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 223. Brazil Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 224. Argentina Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 225. Argentina Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 226. Argentina Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 227. Rest of South America Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 228. Rest of South America Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 229. Rest of South America Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 230. Asia Pacific Subcutaneous Drug Delivery Devices, by Country USD Million (2020-2025)
  • Table 231. Asia Pacific Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 232. Asia Pacific Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 233. Asia Pacific Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 234. China Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 235. China Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 236. China Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 237. Japan Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 238. Japan Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 239. Japan Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 240. India Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 241. India Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 242. India Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 243. South Korea Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 244. South Korea Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 245. South Korea Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 246. Taiwan Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 247. Taiwan Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 248. Taiwan Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 249. Australia Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 250. Australia Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 251. Australia Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 252. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 253. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 254. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 255. Europe Subcutaneous Drug Delivery Devices, by Country USD Million (2020-2025)
  • Table 256. Europe Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 257. Europe Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 258. Europe Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 259. Germany Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 260. Germany Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 261. Germany Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 262. France Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 263. France Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 264. France Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 265. Italy Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 266. Italy Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 267. Italy Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 268. United Kingdom Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 269. United Kingdom Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 270. United Kingdom Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 271. Netherlands Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 272. Netherlands Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 273. Netherlands Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 274. Rest of Europe Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 275. Rest of Europe Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 276. Rest of Europe Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 277. MEA Subcutaneous Drug Delivery Devices, by Country USD Million (2020-2025)
  • Table 278. MEA Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 279. MEA Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 280. MEA Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 281. Middle East Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 282. Middle East Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 283. Middle East Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 284. Africa Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 285. Africa Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 286. Africa Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 287. North America Subcutaneous Drug Delivery Devices, by Country USD Million (2020-2025)
  • Table 288. North America Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 289. North America Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 290. North America Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 291. United States Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 292. United States Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 293. United States Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 294. Canada Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 295. Canada Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 296. Canada Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 297. Mexico Subcutaneous Drug Delivery Devices, by Type USD Million (2020-2025)
  • Table 298. Mexico Subcutaneous Drug Delivery Devices, by Distribution Channel USD Million (2020-2025)
  • Table 299. Mexico Subcutaneous Drug Delivery Devices, by Syringe USD Million (2020-2025)
  • Table 300. Subcutaneous Drug Delivery Devices Sales: by Type(K Unit)
  • Table 301. Subcutaneous Drug Delivery Devices Sales Prefilled syringes , by Region K Unit (2020-2025)
  • Table 302. Subcutaneous Drug Delivery Devices Sales Pen injectors , by Region K Unit (2020-2025)
  • Table 303. Subcutaneous Drug Delivery Devices Sales Auto-injectors , by Region K Unit (2020-2025)
  • Table 304. Subcutaneous Drug Delivery Devices Sales Wearable injectors , by Region K Unit (2020-2025)
  • Table 305. Subcutaneous Drug Delivery Devices Sales Needle-free Injectors , by Region K Unit (2020-2025)
  • Table 306. Subcutaneous Drug Delivery Devices Sales: by Distribution Channel(K Unit)
  • Table 307. Subcutaneous Drug Delivery Devices Sales Hospital pharmacies , by Region K Unit (2020-2025)
  • Table 308. Subcutaneous Drug Delivery Devices Sales Retail pharmacies , by Region K Unit (2020-2025)
  • Table 309. Subcutaneous Drug Delivery Devices Sales Online pharmacies , by Region K Unit (2020-2025)
  • Table 310. Subcutaneous Drug Delivery Devices Sales: by Syringe(K Unit)
  • Table 311. Subcutaneous Drug Delivery Devices Sales Prefilled Injectable , by Region K Unit (2020-2025)
  • Table 312. Subcutaneous Drug Delivery Devices Sales Filled Injectable , by Region K Unit (2020-2025)
  • Table 313. South America Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2020-2025)
  • Table 314. South America Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 315. South America Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 316. South America Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 317. Brazil Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 318. Brazil Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 319. Brazil Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 320. Argentina Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 321. Argentina Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 322. Argentina Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 323. Rest of South America Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 324. Rest of South America Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 325. Rest of South America Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 326. Asia Pacific Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2020-2025)
  • Table 327. Asia Pacific Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 328. Asia Pacific Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 329. Asia Pacific Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 330. China Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 331. China Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 332. China Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 333. Japan Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 334. Japan Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 335. Japan Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 336. India Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 337. India Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 338. India Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 339. South Korea Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 340. South Korea Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 341. South Korea Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 342. Taiwan Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 343. Taiwan Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 344. Taiwan Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 345. Australia Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 346. Australia Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 347. Australia Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 348. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 349. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 350. Rest of Asia-Pacific Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 351. Europe Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2020-2025)
  • Table 352. Europe Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 353. Europe Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 354. Europe Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 355. Germany Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 356. Germany Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 357. Germany Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 358. France Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 359. France Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 360. France Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 361. Italy Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 362. Italy Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 363. Italy Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 364. United Kingdom Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 365. United Kingdom Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 366. United Kingdom Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 367. Netherlands Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 368. Netherlands Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 369. Netherlands Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 370. Rest of Europe Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 371. Rest of Europe Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 372. Rest of Europe Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 373. MEA Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2020-2025)
  • Table 374. MEA Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 375. MEA Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 376. MEA Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 377. Middle East Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 378. Middle East Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 379. Middle East Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 380. Africa Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 381. Africa Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 382. Africa Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 383. North America Subcutaneous Drug Delivery Devices Sales, by Country K Unit (2020-2025)
  • Table 384. North America Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 385. North America Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 386. North America Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 387. United States Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 388. United States Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 389. United States Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 390. Canada Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 391. Canada Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 392. Canada Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 393. Mexico Subcutaneous Drug Delivery Devices Sales, by Type K Unit (2020-2025)
  • Table 394. Mexico Subcutaneous Drug Delivery Devices Sales, by Distribution Channel K Unit (2020-2025)
  • Table 395. Mexico Subcutaneous Drug Delivery Devices Sales, by Syringe K Unit (2020-2025)
  • Table 396. Subcutaneous Drug Delivery Devices: by Type(USD/Units)
  • Table 397. Research Programs/Design for This Report
  • Table 398. Key Data Information from Secondary Sources
  • Table 399. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Subcutaneous Drug Delivery Devices: by Type USD Million (2014-2019)
  • Figure 5. Global Subcutaneous Drug Delivery Devices: by Distribution Channel USD Million (2014-2019)
  • Figure 6. Global Subcutaneous Drug Delivery Devices: by Syringe USD Million (2014-2019)
  • Figure 7. South America Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 8. Asia Pacific Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 9. Europe Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 10. MEA Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 11. North America Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 12. Global Subcutaneous Drug Delivery Devices: by Type K Unit (2014-2019)
  • Figure 13. Global Subcutaneous Drug Delivery Devices: by Distribution Channel K Unit (2014-2019)
  • Figure 14. Global Subcutaneous Drug Delivery Devices: by Syringe K Unit (2014-2019)
  • Figure 15. South America Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 16. Asia Pacific Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 17. Europe Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 18. MEA Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 19. North America Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 20. Global Subcutaneous Drug Delivery Devices: by Type USD/Units (2014-2019)
  • Figure 21. Global Subcutaneous Drug Delivery Devices share by Players 2019 (%)
  • Figure 22. Global Subcutaneous Drug Delivery Devices share by Players (Top 3) 2019(%)
  • Figure 23. Global Subcutaneous Drug Delivery Devices share by Players (Top 5) 2019(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Gerresheimer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Gerresheimer AG (Germany) Revenue: by Geography 2019
  • Figure 27. Medtronic Plc (United States) Revenue, Net Income and Gross profit
  • Figure 28. Medtronic Plc (United States) Revenue: by Geography 2019
  • Figure 29. Ypsomed AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 30. Ypsomed AG (Switzerland) Revenue: by Geography 2019
  • Figure 31. Elcam Medical Group (Israel) Revenue, Net Income and Gross profit
  • Figure 32. Elcam Medical Group (Israel) Revenue: by Geography 2019
  • Figure 33. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 34. Novo Nordisk (Denmark) Revenue: by Geography 2019
  • Figure 35. Insulet Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Insulet Corporation (United States) Revenue: by Geography 2019
  • Figure 37. Becton, Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 38. Becton, Dickinson and Company (United States) Revenue: by Geography 2019
  • Figure 39. West Pharmaceutical Services, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. West Pharmaceutical Services, Inc. (United States) Revenue: by Geography 2019
  • Figure 41. Sanofi. (France) Revenue, Net Income and Gross profit
  • Figure 42. Sanofi. (France) Revenue: by Geography 2019
  • Figure 43. PharmaJet (United States) Revenue, Net Income and Gross profit
  • Figure 44. PharmaJet (United States) Revenue: by Geography 2019
  • Figure 45. Global Subcutaneous Drug Delivery Devices: by Type USD Million (2020-2025)
  • Figure 46. Global Subcutaneous Drug Delivery Devices: by Distribution Channel USD Million (2020-2025)
  • Figure 47. Global Subcutaneous Drug Delivery Devices: by Syringe USD Million (2020-2025)
  • Figure 48. South America Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 49. Asia Pacific Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 50. Europe Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 51. MEA Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 52. North America Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 53. Global Subcutaneous Drug Delivery Devices: by Type K Unit (2020-2025)
  • Figure 54. Global Subcutaneous Drug Delivery Devices: by Distribution Channel K Unit (2020-2025)
  • Figure 55. Global Subcutaneous Drug Delivery Devices: by Syringe K Unit (2020-2025)
  • Figure 56. South America Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 57. Asia Pacific Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 58. Europe Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 59. MEA Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 60. North America Subcutaneous Drug Delivery Devices Share (%), by Country
  • Figure 61. Global Subcutaneous Drug Delivery Devices: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Gerresheimer AG (Germany)
  • Medtronic Plc (United States)
  • Ypsomed AG (Switzerland)
  • Elcam Medical Group (Israel)
  • Novo Nordisk (Denmark)
  • Insulet Corporation (United States)
  • Becton, Dickinson and Company (United States)
  • West Pharmaceutical Services, Inc. (United States)
  • Sanofi. (France)
  • PharmaJet (United States)
Additional players considered in the study are as follows:
Unilife Corporation (United States) , Inolife Sciences (Canada)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation